To explore the role of ecARNT in angiogenesis during diabetes, we conducted a series of studies in mice carrying a tamoxifen-inducible, EC-specific ARNT-knockout (ArntΔEC, ERT2) mutation. The gene discussed is MAPK3; the disease is diabetes mellitus.